NYSE:ABBV
AbbVie Inc.
AbbVie Inc.'s revenue grew 8.6% in fiscal 2025 to $61.2B while operating margin rose to 24.6%. Free cash flow was $17.8B, 29.1% of revenue.Summary generated from AbbVie Inc.'s SEC filings. Latest annual report filed Feb 20, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$61.2B
Revenue growth+8.6%
Revenue, 5-yr CAGR+6.0%
Gross margin70.2%
Operating margin24.6%
Net margin6.9%
ROIC15.7%
Return on equity15367.3%
Debt / equityn/a
Free cash flow$17.8B
FCF margin29.1%
Share count change+0.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 56.2 | 58.1 | 54.3 | 56.3 | 61.2 |
| Operating income | 17.9 | 18.1 | 12.8 | 9.1 | 15.1 |
| Net income | 11.5 | 11.8 | 4.9 | 4.3 | 4.2 |
| Free cash flow | 22.0 | 24.2 | 22.1 | 17.8 | 17.8 |
Recent filings
- 8-KResults of operations and financial condition
Oct 5, 2026 - 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 8-KRegulation FD disclosure
Sep 3, 2026 - 8-KOther events
Aug 18, 2026 - 8-KOther events
Aug 5, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 3, 2026 - 8-KResults of operations and financial condition
Jul 31, 2026